Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

TissUse is a Berlin, Germany-based, vibrant growth company who has developed a unique "Multi-Organ-Chip" platform that - for the first time ever - provides preclinical insight on the systemic level using human tissue. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUse's Multi-Organ-Chips provide a completely new approach to predict, for example, toxicity, ADME profiles and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials.

BI/OND empowers diversity in biological studies by engineering microchips. We are all different in unique ways, yet modern treatments ignore individuals’ genetic variations. People from different ethnicities, gender, ages are limited to take drugs based on a genetic set entirely different from their own. We invented a computer chip where biologists can put your cells. The chip nourishes, stimulates and monitors them as they were in your body. All these functionalities allow finding the medicine specifically meant for you.

Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.

Eden Microfluidics is a young innovative company founded in 2017. The company aims to provide advanced and certified materials, microfabrication and microfluidics solutions to both researchers and industrial partners. Eden Microfluidics is driven by a team of talented and passionate scientists, innovators and entrepreneurs, thriving to develop radical microfluidic solutions, for biomedical to environmental challenges. All together, they assemble a large IP portfolio of polymer and epoxy formulations, cellular micro-environment and microfluidic remediation systems. Eden Microfluidics is here to offer you access to the latest, up-to-date microfluidic science and technology.

Jiangsu Aiweide Biotechnology Co., Ltd., established on 2021-11-11, Business scope includes licensed projects:Production of Class II Medical Devices;Internet Information Service for Medical Devices;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;New material technology research and development;Human stem cell technology development and application;Production of Class I Medical Devices;Sales of Class I Medical Devices;Class II Medical Device Leasing;Sales of Class II Medical Devices;Artificial intelligence application software development;Technology intermediary service;Conference and Exhibition Services;business training(Does not include education and training,Vocational skills training and other licensed training)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Mepsgen Co. Ltd. is a South Korean company located in Songpa-gu that operates as a biotechnology research company. The firm was founded in 2019 by Kim YongTae and Robert Langer. Kim YongTae has been the CEO since the company founding.

BGI Research is a private company headquartered in Yantian, China, that focuses on genomics, transcriptomics, proteomics, metabolomics and other omics research studies.